Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of High Intensity Statin Therapy on Steroid Hormones in Type 2 Diabetic Men
NCT05806723Phase 4Completed
- Sponsor
- Hôpital La Rabta
- Start
- Mar 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in dyslipidemia and cardiovascular diseases (CVD), sponsored by Hôpital La Rabta. Primary endpoint: Change in testosterone level at 6 months. Started Mar 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
dyslipidemiacardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT05806723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05806723.